Hilma Biocare
Retatrutide
Triple GIP/GLP-1/Glucagon agonist. Next-generation metabolic research compound.
98.5%· Janoshik
Next-generation triple agonist GIP/GLP-1/Glucagon receptor. The most potent metabolic research peptide available — Reta by ZPHC in vials, pens and multi-dose kits.
10 products
Hilma Biocare
Triple GIP/GLP-1/Glucagon agonist. Next-generation metabolic research compound.
98.5%· Janoshik

ZPHC
Retatrutide 10mg (5×2mg) lyophilized by ZPHC. Triple GIP/GLP-1/Glucagon agonist.
99%+· ZPHC

ZPHC
Retatrutide 15mg single vial by ZPHC. Starter dose for triple agonist research.
99%+· ZPHC

ZPHC
Retatrutide 20mg kit (5×4mg) by ZPHC. GIP/GLP-1/Glucagon triple agonist.
99%+· ZPHC

ZPHC
Retatrutide 30mg premixed AQ auto-injector pen by ZPHC. Ready-to-use.
99%+· ZPHC

ZPHC
Retatrutide 40mg kit (5×8mg) by ZPHC. Best value mid-dose research kit.
99%+· ZPHC

ZPHC
Retatrutide 60mg kit (5×12mg) lyophilized by ZPHC. Full-cycle research supply.
99%+· ZPHC

ZPHC
Retatrutide 60mg dual-chamber auto-mixing pen + sterile water by ZPHC.
99%+· ZPHC

ZPHC
Retatrutide 120mg bulk kit (5×24mg) by ZPHC. Maximum-supply research format.
99%+· ZPHC

Landex Pharma
GIP / GLP-1 / glucagon triple agonist. Supplied by Landex Pharma for laboratory research.
Not yet available
Resellers, laboratories and publishers: apply for partner pricing, volume terms and a dedicated representative.
Research use only. All products are sold strictly for in-vitro and laboratory research. Not for human consumption, veterinary use, diagnosis, treatment or prevention of any disease. Products sold by JuicedPharma are not medicines. By ordering you confirm you are a qualified person buying for research in compliance with applicable regulations. Full disclaimer